Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
D 56.52 -2.84% -1.65
LNTH closed down 2.84 percent on Monday, March 18, 2024, on approximately normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
Stochastic Buy Signal Bullish 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -2.84%
Multiple of Ten Bearish Other -2.84%
Outside Day Range Expansion -2.84%
Oversold Stochastic Weakness -2.84%
NR7 Range Contraction -5.53%
Multiple of Ten Bearish Other -5.53%

   Recent Intraday Alerts

Alert Time
Down 2 % about 14 hours ago
60 Minute Opening Range Breakdown about 14 hours ago
Possible NR7 about 15 hours ago
Fell Below Previous Day's Low about 20 hours ago
Down 1% about 20 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lantheus Holdings, Inc. Description

Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Disease Chemical Elements Prostate Cancer Heart Failure Medical Imaging Stroke Medical Physics Perfusion Artery Radiopharmaceuticals Artery Disease Congestive Heart Failure Imaging Agent Peripheral Vascular Disease Coronary Artery Disease Gallium Neuron Cardiovascular And Other Diseases Medicinal Radiochemistry Myocardial Perfusion Imaging

Is LNTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 100.8505
52 Week Low 50.2
Average Volume 1,183,897
200-Day Moving Average 69.16
50-Day Moving Average 58.47
20-Day Moving Average 62.57
10-Day Moving Average 60.93
Average True Range 2.31
RSI (14) 37.11
ADX 20.02
+DI 19.66
-DI 29.35
Chandelier Exit (Long, 3 ATRs) 62.79
Chandelier Exit (Short, 3 ATRs) 63.00
Upper Bollinger Bands 69.73
Lower Bollinger Band 55.40
Percent B (%b) 0.08
BandWidth 22.91
MACD Line -0.08
MACD Signal Line 0.89
MACD Histogram -0.9763
Fundamentals Value
Market Cap 3.87 Billion
Num Shares 68.5 Million
EPS 1.50
Price-to-Earnings (P/E) Ratio 37.68
Price-to-Sales 3.21
Price-to-Book 5.51
PEG Ratio 0.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 59.81
Resistance 3 (R3) 60.14 59.39 59.26
Resistance 2 (R2) 59.39 58.55 59.22 59.07
Resistance 1 (R1) 57.95 58.03 57.58 57.62 58.89
Pivot Point 57.20 57.20 57.01 57.03 57.20
Support 1 (S1) 55.76 56.36 55.39 55.43 54.15
Support 2 (S2) 55.01 55.84 54.84 53.97
Support 3 (S3) 53.57 55.01 53.78
Support 4 (S4) 53.24